LT3094616T - Medžiagos, kurioje yra glicerilo tribenzoato, naudojimas gydant neurodegeneracinius sutrikimus - Google Patents

Medžiagos, kurioje yra glicerilo tribenzoato, naudojimas gydant neurodegeneracinius sutrikimus

Info

Publication number
LT3094616T
LT3094616T LTEP15737329.1T LT15737329T LT3094616T LT 3094616 T LT3094616 T LT 3094616T LT 15737329 T LT15737329 T LT 15737329T LT 3094616 T LT3094616 T LT 3094616T
Authority
LT
Lithuania
Prior art keywords
neurodeggenic
disorders
treatment
substance containing
containing glyceryl
Prior art date
Application number
LTEP15737329.1T
Other languages
English (en)
Lithuanian (lt)
Inventor
Kalipada PAHAN
Original Assignee
Rush University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rush University Medical Center filed Critical Rush University Medical Center
Publication of LT3094616T publication Critical patent/LT3094616T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
LTEP15737329.1T 2014-01-17 2015-01-16 Medžiagos, kurioje yra glicerilo tribenzoato, naudojimas gydant neurodegeneracinius sutrikimus LT3094616T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461928622P 2014-01-17 2014-01-17
PCT/US2015/011798 WO2015109215A1 (en) 2014-01-17 2015-01-16 The use of a benzoate containing composition in urea cycle disorders and neurodegenerativre disordrs

Publications (1)

Publication Number Publication Date
LT3094616T true LT3094616T (lt) 2021-04-12

Family

ID=53543490

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP15737329.1T LT3094616T (lt) 2014-01-17 2015-01-16 Medžiagos, kurioje yra glicerilo tribenzoato, naudojimas gydant neurodegeneracinius sutrikimus

Country Status (16)

Country Link
US (1) US9968582B2 (enExample)
EP (1) EP3094616B1 (enExample)
JP (2) JP6836905B2 (enExample)
CA (1) CA2936548C (enExample)
CY (1) CY1124115T1 (enExample)
DK (1) DK3094616T3 (enExample)
ES (1) ES2853974T3 (enExample)
HR (1) HRP20210361T1 (enExample)
HU (1) HUE053671T2 (enExample)
LT (1) LT3094616T (enExample)
PL (1) PL3094616T3 (enExample)
PT (1) PT3094616T (enExample)
RS (1) RS61611B1 (enExample)
SI (1) SI3094616T1 (enExample)
SM (1) SMT202100074T1 (enExample)
WO (1) WO2015109215A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11304923B2 (en) 2017-10-06 2022-04-19 Rush University Medical Center Use of a benzoate containing composition to treat glycine encephalopathy
US11826326B2 (en) * 2017-11-22 2023-11-28 Excelsior Pharmatech Labs Benzoic acid or a salt and derivative thereof for use in preventing or treating depression
AU2020229316A1 (en) * 2019-02-25 2021-09-16 Rush University Medical Center Compositions including cinnamic acid and methods of use thereof
JP2022541021A (ja) * 2019-07-16 2022-09-21 ラッシュ・ユニバーシティ・メディカル・センター 神経変性障害を治療するためのベンゾエート含有組成物の使用
WO2022093922A1 (en) * 2020-10-28 2022-05-05 Rush University Medical Center Use of a cinnamein composition for the treatment of glycine encephalopathy and urea cycle disorders
EP4262781A4 (en) * 2020-12-16 2025-02-12 Rush University Medical Center Administration of glycerol tribenzoate and glycerol phenylbutyrate for treatment of neurodegenerative and urea cycle disorders
CA3241282A1 (en) * 2021-12-16 2023-06-22 Kalipada PAHAN Benzoic acid salts for treatment of nervous system injuries and disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284647A (en) * 1980-03-31 1981-08-18 The Johns Hopkins University Process for waste nitrogen removal
WO2008083226A2 (en) 2006-12-28 2008-07-10 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate

Also Published As

Publication number Publication date
CY1124115T1 (el) 2022-05-27
WO2015109215A1 (en) 2015-07-23
CA2936548C (en) 2022-08-30
EP3094616B1 (en) 2020-12-23
RS61611B1 (sr) 2021-04-29
JP6836905B2 (ja) 2021-03-03
US9968582B2 (en) 2018-05-15
EP3094616A4 (en) 2017-08-23
JP2020037558A (ja) 2020-03-12
PL3094616T3 (pl) 2021-05-31
US20160331714A1 (en) 2016-11-17
JP2017505811A (ja) 2017-02-23
SMT202100074T1 (it) 2021-05-07
HRP20210361T1 (hr) 2021-04-16
DK3094616T3 (da) 2021-02-15
HUE053671T2 (hu) 2021-07-28
ES2853974T3 (es) 2021-09-20
CA2936548A1 (en) 2015-07-23
EP3094616A1 (en) 2016-11-23
PT3094616T (pt) 2021-03-03
SI3094616T1 (sl) 2021-07-30

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
BR112015007494A2 (pt) aparelho para tratamento dentário.
PL3157512T3 (pl) Zastosowanie kannabidioli w leczeniu padaczki
PL3936130T3 (pl) Schemat dawkowania walbenazyny w leczeniu hiperkinetycznych zaburzeń ruchu
HUE061761T2 (hu) Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
IL260684B (en) Treatment for modulating gut microbiota
IL247354A0 (en) Treatment of conditions associated with hyperinsulinaemia
DK3104838T3 (da) Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf
GB201408080D0 (en) Skin care composition
LT3094616T (lt) Medžiagos, kurioje yra glicerilo tribenzoato, naudojimas gydant neurodegeneracinius sutrikimus
DK3302519T3 (da) Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom
IL283335B (en) Dihydropyrimidine-2-one compounds and their medical use
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
DK3114118T3 (da) p-SUBSTITUEREDE ASYMMETRISKE URINSTOFFER OG MEDICINSK ANVENDELSE DERAF
IL251345A0 (en) Compositions for use in the treatment of peri-implantitis
PL3145592T3 (pl) Kompozycja do pielęgnacji skóry
IL252574A0 (en) Oral care product
LT3229790T (lt) Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme
HUE046209T2 (hu) Kompozíció porckoronggal összefüggõ fájdalom kezelésében történõ alkalmazásra
GB201510808D0 (en) Patient care pathway shape analysis
PL3166599T3 (pl) Postać dawkowania w formie kapsułek zawierających bursztynian metoprololu
HUE047174T2 (hu) Imepitoin epilepsziás rendellenességek kezelésére történõ alkalmazásra macskafélékben
HUE057830T2 (hu) Famitinib tartalmú gyógyszerkészítmény
DE112014006426A5 (de) Kartusche mit Stechmittel zum hygienischen Einbringen von Stoffen in eine Haut